Dambkowski Carl bought APGE

August 5, 2026 · Form 4 insider transaction

Dambkowski Carl bought 4,125 shares of Apogee Therapeutics, Inc. at $22.86 per share, a transaction worth $94.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.